First nasal medicine to treat anaphylactic reactions
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has approved Eurneffy (epinephrine) for use in the European Union. This medicine is the first to be administered through the nose to treat anaphylactic reaction emergencies and offers new hope for those suffering from severe allergies.
If you need more information about regulatory services, ELS can certainly help.
ontact your local ELS consultant or via email info@elssolutions.pt
